Febuxostat may reduce gout flares – recent trial

Share Button

febuxostat, gout, gout treatment, gout drug, gout pain, arthritis magazineA drug called febuxostat reduced gout flares in a study of 314 adults with early gout, experts report in Arthritis & Rheumatology. The drug also reduced synovitis (which is inflammation of the joint lining) over a two-year period compared with placebo.

“Current clinical practice guidelines do not recommend routine use of urate-lowering therapy for people after the first gout flare,” explains lead author Dr Nicola Dalbeth. “This study indicates that even for people who have had only one or two prior gout flares, urate-lowering therapy to reduce serum urate below 6mg/dL may have benefit in reducing future flares.”

For more in-depth features, interviews and information, subscribe to Arthritis Digest magazine, a popular title that’s published six times a year. Click here for the digital version or tel 0845 643 8470 to order your had copy. You’ll know what your doctor is talking about, what new drugs are in the pipeline and be up to date on helpful products.

“Amazing magazine and the first I’ve read from beginning to end.” Mrs E Crowther, Dorset

“There’s so much news and information to digest, and it’s all calorie free. Brilliant!” A Alexander, Glasgow
“As we are all living longer, it gives us hope for a future with less pain. Arthritis Digest gives us information on the up to date treatments.”Mrs Healey, Devon
“Full of interesting information and tips.” Mr G Thurlow, East Yorkshire

Google+ | Privacy Policy | FTC Disclaimer

Copyright © 2013. All Rights Reserved.